Search results - 2 results

Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination.

delivery or vaccination against infectious diseases or tumours, even in immunocompromised individuals. The use of MVA and recombinant MVA vectors must comply with various regulatory requirements, ...

Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.

Mycobacterium tuberculosis Th1 Cells Tuberculosis Tuberculosis Vaccines Vaccines, DNA Abstract: Novel vaccines are needed to control tuberculosis (TB), the bacterial infectious disease that together with malaria ...

QR code

QR code for this page URL